These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 10425349
21. Reactive radical intermediates formed from illuminated nifedipine. Stasko A, Brezová V, Biskupic S, Ondrias K, Misík V. Free Radic Biol Med; 1994 Dec; 17(6):545-56. PubMed ID: 7867971 [Abstract] [Full Text] [Related]
22. Newly discovered photodegradation products of nifedipine in hospital prescriptions. Hayase N, Itagaki Y, Ogawa S, Akutsu S, Inagaki S, Abiko Y. J Pharm Sci; 1994 Apr; 83(4):532-8. PubMed ID: 8046608 [Abstract] [Full Text] [Related]
27. The interaction of nifedipine with selected cyclodextrins and the subsequent solubility-permeability trade-off. Beig A, Miller JM, Dahan A. Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1293-9. PubMed ID: 23770429 [Abstract] [Full Text] [Related]
34. A study of the photo-degradation kinetics of nifedipine by multivariate curve resolution analysis. Shamsipur M, Hemmateenejad B, Akhond M, Javidnia K, Miri R. J Pharm Biomed Anal; 2003 Apr 01; 31(5):1013-9. PubMed ID: 12684114 [Abstract] [Full Text] [Related]
35. Photostability of drugs: photodegradation of melatonin and its determination in commercial formulations. Andrisano V, Bertucci C, Battaglia A, Cavrini V. J Pharm Biomed Anal; 2000 Aug 01; 23(1):15-23. PubMed ID: 10898150 [Abstract] [Full Text] [Related]
39. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries. Kanda M, Shirahase H, Kurahashi K, Wada K, Nakamura S, Matsui H, Fukata F. Arzneimittelforschung; 1995 Aug 01; 45(8):831-5. PubMed ID: 7575741 [Abstract] [Full Text] [Related]